Prognostic significance prostate specific antigen endocrine treatment prostatic cancer prognostic value prostate specific antigen disease progression endocrine therapy patients prostatic cancer total patients stage stage stage stage disease Endocrine therapy bilateral orchiectomy diethylstilbestrol diphosphate hormone-releasing hormone analogue Pre-treatment serum prostate specific antigen levels patients enzyme immunoassay kit followup months average months clinical disease progression patients pre-treatment prostate specific antigen level predict disease progression Changes prostate specific antigen level treatment interval progression patients prostate specific antigen determinations regular intervals endocrine therapy initial level ng./ml Patients decrease prostate specific antigen levels month beginning therapy free disease progression prostate specific antigen level elevated months high risk disease progression years study patients favorable prognosis early months endocrine therapy rapid decrease prostate specific antigen levels 